Glooko® Enterprise provides data unity and analytics that deliver actionable insights to help accelerate care decisions.
Glooko provides digital health software that aims to improve the quality of life for diabetic patients, as well as those who care for them. We do this by simplifying collaboration, making it easy to share diabetes data and personal insights.
Glooko transforms digital health by connecting individuals with diabetes and their healthcare professionals, enabling clinical research, telehealth, and improved collaboration.
Digital health software platforms for diabetes data management
Glooko’s platforms are compatible with the vast majority of diabetes devices on-market, giving people with diabetes, as well as their care teams the freedom of choice.
Our software platforms, Glooko® and diasend®, empower diabetes management by collecting and unlocking data from insulin pumps and pens, continuous glucose monitoring (CGM), activity trackers, and blood-glucose meters, combining insights in one place.
Data from diabetes devices and activity trackers can be uploaded effortlessly, either remotely via an app or in-clinic, with data securely shared and viewed in actionable charts and graphs.
This makes it easy to see how insulin, food intake and activity affect blood sugar levels, creating a solid foundation for collaboration, confident treatment decisions and self-care.
Personal data and protected health information
Glooko understands the significance of trust and security of personal data and protected health information, which is why the company introduced formal security and privacy governance. We also regularly report on both privacy and security to the company’s board of directors.
Our company’s leadership team is involved in and committed to privacy and security governance, enabling the protection of personal and protected data to be its highest priority in every aspect of culture and practice.
We are a trusted partner:
- Proactive threat monitoring to identify and respond to threats
- Ongoing vulnerability scanning to continually improve security of the platform
- Active availability and performance monitoring to ensure platform responsiveness and rapid response to issues
- 3rd party objective assessments, including yearly penetration testing and cybersecurity risk assessment
- HIPAA and GDPR ready
- Ethical, legal, principled use of data baked into policies and culture
So far, 2.8 million users have benefited from diabetes data insights using Glooko’s solutions, trusted by global leaders in diabetes care, and used in 26 countries across 15 languages.
Glooko is currently offering a secure, privacy-protected Glooko Remote Care solution to medical clinics as a public service to broaden access to remote diabetes care during the Covid-19 pandemic, as well as help to reduce the risk of possible exposure to the virus for diabetic patients.
Glooko Announces New Medical Education Programme In Collaboration with the Diabetes Technology Network (DTN)/ Association of British Clinical Diabetologists (ABCD)
Glooko announced, in partnership with the Diabetes Technology Network (DTN)/ Association of British Clinical Diabetologists (ABCD), a new online medical education programme for clinicians who treat people with diabetes in the UK.